89bio, Inc. (ETNB)
USD 7.61
(-4.64%)
USD 7.61
(-4.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -129.18 Million | -81.09 Million | -76.78 Million | -46.24 Million | -25.46 Million | -12.46 Million |
| Net Income | -142.18 Million | -102.02 Million | -90.12 Million | -49.49 Million | -57.42 Million | -16.17 Million |
| Depreciation & Amortization | 273 Thousand | 65 Thousand | 79 Thousand | 60 Thousand | 17 Thousand | 6000.00 |
| Deferred income taxes | 127 Thousand | - | -150 Thousand | -69 Thousand | 20 Thousand | -20 Thousand |
| Stock-based compensation | 16.1 Million | 10.35 Million | 8.67 Million | 3.8 Million | 389 Thousand | 108 Thousand |
| Change in working capital | 657 Thousand | 10.55 Million | 3.25 Million | -1.04 Million | 937 Thousand | 2.63 Million |
| Other non-cash items | -4.16 Million | -41 Thousand | 1.48 Million | 498 Thousand | 30.59 Million | 979 Thousand |
| Investing Cash Flow | -123.01 Million | -33.94 Million | 7.15 Million | -106.83 Million | -139 Thousand | -39 Thousand |
| Investments in PPE | -4000.00 | -7000.00 | -63 Thousand | -126 Thousand | -139 Thousand | -39 Thousand |
| Acquisitions | - | 33.93 Thousand | -7222.00 | 106.7 Thousand | - | - |
| Investment purchases | -341.14 Million | -152.69 Million | -141.2 Million | -118.89 Million | - | - |
| Sales/Maturities of investments | 218.13 Million | 118.76 Million | 148.42 Million | 12.18 Million | - | - |
| Other Investing Activities | -123.01 Thousand | -33.93 Thousand | 7222.00 | -106.7 Thousand | - | - |
| Financing Cash Flow | 513.11 Million | 117.83 Million | 23.87 Million | 157.92 Million | 107.7 Million | 23.76 Million |
| Debt repayment | -2.96 Million | - | -19.95 Million | - | - | -100 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -2.27 Million | -298 Thousand | 144 Thousand | 134 Thousand | - | - |
| Common Stock Issuance | 512.42 Million | 118.12 Million | 3.92 Million | 157.68 Million | 87.7 Million | 23.66 Million |
| Other Financing Activities | -2.27 Million | 118.12 Million | 3.92 Million | 110 Thousand | 20 Million | 23.76 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -3.91 Million | 5.65 Million | 4.77 Million | 1.13 Million | -520 Thousand | 1.5 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 4.57 Million | 4.89 Million | -1.52 Million | -2.17 Million | 1.45 Million | 1.12 Million |
| Cash at beginning of period | 55.25 Million | 52.45 Million | 98.2 Million | 93.36 Million | 11.25 Million | - |
| Cash at end of period | 316.16 Million | 55.25 Million | 52.45 Million | 98.2 Million | 93.36 Million | 11.25 Million |
| Capital Expenditure | -4000.00 | -7000.00 | -63 Thousand | -126 Thousand | -139 Thousand | -39 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 260.9 Million | 2.79 Million | -45.75 Million | 4.84 Million | 82.1 Million | 11.25 Million |
| Free Cash Flow | -129.19 Million | -81.09 Million | -76.84 Million | -46.37 Million | -25.59 Million | -12.5 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -47.97 Million | -51.68 Million | -142.18 Million | -40.23 Million | -34.72 Million | -38.39 Million |
| Depreciation & Amortization | 12 Thousand | 9000.00 | 273 Thousand | 16 Thousand | 10 Thousand | 10 Thousand |
| Deferred income taxes | - | - | 127 Thousand | 127 Thousand | -2.1 Million | -1.14 Million |
| Stock-based compensation | 5.16 Million | 4.99 Million | 16.1 Million | 4.03 Million | 4.38 Million | 4.13 Million |
| Change in working capital | -16.24 Million | 9.43 Million | 657 Thousand | 3.43 Million | 1.8 Million | 668 Thousand |
| Other non-cash items | 831 Thousand | -4.23 Million | -4.16 Million | -1.66 Million | 281 Thousand | 279 Thousand |
| Investing Cash Flow | 27.84 Million | -79.89 Million | -123.01 Million | -63.64 Million | 38.32 Million | -101.8 Million |
| Investments in PPE | - | - | -4000.00 | -4000.00 | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -78.1 Million | -152.03 Million | -341.14 Million | -124.34 Million | -36.22 Million | -146.8 Million |
| Sales/Maturities of investments | 105.95 Million | 72.14 Million | 218.13 Million | 60.7 Million | 74.54 Million | 45 Million |
| Other Investing Activities | 27.84 Million | -79.89 Million | -123.01 Thousand | -63.63 Thousand | 38.32 Thousand | -101.8 Thousand |
| Financing Cash Flow | 27.96 Million | 21.03 Million | 513.11 Million | 162.17 Million | -1.48 Million | 30.76 Million |
| Debt repayment | - | - | -2.96 Million | -42.8 Million | - | -21.4 Million |
| Dividends payments | - | - | - | -693.00 | - | - |
| Common Stock Repurchased | -39 Thousand | -1.68 Million | -2.27 Million | 15 Thousand | -1.59 Million | - |
| Common Stock Issuance | 27.86 Million | 22.96 Million | 512.42 Million | 162.15 Million | 117 Thousand | 30.76 Million |
| Other Financing Activities | 98 Thousand | -1.93 Million | -2.27 Million | 15 Thousand | -1.59 Million | 21.4 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 2.23 Million | 6.76 Million | -3.91 Million | -2.31 Million | 188 Thousand | -6.01 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -18.48 Million | 2.67 Million | 4.57 Million | 5.74 Million | 1.61 Million | 6.68 Million |
| Cash at beginning of period | 217.57 Million | 316.16 Million | 55.25 Million | 251.92 Million | 245.44 Million | 350.93 Million |
| Cash at end of period | 212.21 Million | 217.57 Million | 316.16 Million | 316.16 Million | 251.92 Million | 245.44 Million |
| Capital Expenditure | - | - | -4000.00 | -4000.00 | - | - |
| Effect of forex changes on cash | - | - | - | -108.07 Million | - | 108.07 Million |
| Net cash flow / Change in cash | -5.35 Million | -98.58 Million | 260.9 Million | 64.23 Million | 6.48 Million | -105.48 Million |
| Free Cash Flow | -61.16 Million | -39.72 Million | -129.19 Million | -34.29 Million | -30.36 Million | -34.44 Million |
AAJ
TIRTPLS
002058
ZPRS
9551
OPRT